Search results for "Peak Expiratory Flow Rate"

showing 10 items of 15 documents

Comparison of the effects of salmeterol and salbutamol on clinical activity and eosinophil cationic protein serum levels during the pollen season in …

1995

In atopic asthma there is strong evidence of eosinophils playing an active role in pathogenesis. Some investigations demonstrated that eosinophil cationic protein (ECP) serum levels increased in atopic patients with asthma during pollen season.The aim of the study was to evaluate the effects of short-term (1 week) beta 2-agonist treatment on lung function and eosinophil activity in asthmatic patients.We used an open, randomized, cross-over design to compare the effects of salbutamol (200 micrograms q.i.d.) and salmeterol (50 micrograms b.i.d.) on peak expiratory flow rate (PEFR), blood eosinophil count and serum levels of ECP as a measure of eosinophil activity in 20 mild atopic asthmatics.…

AdultHypersensitivity ImmediateMalemedicine.medical_specialtymedicine.drug_classImmunologyCell CountPeak Expiratory Flow RateLeukocyte CountRibonucleasesimmune system diseasesForced Expiratory VolumeBronchodilatorInternal medicinemedicineHumansImmunology and AllergyAlbuterolEosinophil degranulationSalmeterol XinafoateAsthmaEosinophil cationic proteinCross-Over Studiesbusiness.industryEosinophil Granule ProteinsRhinitis Allergic SeasonalBlood ProteinsEosinophil Granule ProteinsMiddle Agedrespiratory systemEosinophilmedicine.diseaseAsthmarespiratory tract diseasesEosinophilsEndocrinologymedicine.anatomical_structureSalbutamolPollenFemaleSalmeterolbusinesscirculatory and respiratory physiologymedicine.drugClinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy
researchProduct

Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study

2012

SummaryBackgroundStudies with inhaled corticosteroids (ICS) in smoking asthmatics have mostly shown poorer treatment responses than in non-smoking asthmatics.MethodsEuroSMART, an open, randomised, 6-month study, compared budesonide/formoterol (Symbicort ® Turbuhaler®)hhNeither the Symbicort SMART posology nor the dry powder formulation, Turbuhaler, is currently approved in the US. maintenance and reliever therapy (Symbicort SMART®) at two maintenance doses of budesonide/formoterol (160/4.5 μg), 1 × 2 and 2 × 2, in patients with asthma who were symptomatic despite treatment with ICS ± long-acting β2-agonists. The 8424 randomised patients included 886 smokers (11%; aged <40 years or with a sm…

AdultMaleBudesonidePulmonary and Respiratory MedicineSymbicort SMARTmedicine.medical_specialtyPeak Expiratory Flow RatePropensity-matched controlsDrug Administration Schedulelaw.inventionACQ-5Budesonide/formoterol maintenance and reliever therapyPharmacotherapyRandomized controlled triallawFormoterol FumarateSurveys and QuestionnairesInternal medicineAdministration InhalationmedicineHumansAnti-Asthmatic AgentsDosingBudesonideAsthmaSmokersDose-Response Relationship Drugbusiness.industrySmokingmedicine.diseaseAsthmaBronchodilator Agentsrespiratory tract diseasesTreatment OutcomeBudesonide/formoterolEthanolaminesAnesthesiaDisease ProgressionDrug Therapy CombinationFemaleFormoterol FumarateFormoterolbusinessmedicine.drugRespiratory Medicine
researchProduct

Characteristics and Prognostic Value of Morning Dipping of Peak Expiratory Flow Rate in Stable Asthmatic Subjects

1985

Characteristics and prognostic relevance of morning dip of peak expiratory flow rate (PEFR) were evaluated in stable asthmatic subjects. Among 246 outpatients monitored four times daily for two weeks, 38 (group A) showed a significant difference between morning reading of PEFR and each of the others; they were compared to 38 randomly selected patients (group B) not showing morning dip in PEFR. Less frequent seasonal course, extrinsic pathogenesis, and sensitization to mites characterized group A; starting airflow limitation was more severe in those with morning dip, but no significant difference between mean PEFR measured throughout two weeks was found. At 6 to 12 weeks, morning dip was not…

AdultMalePulmonary and Respiratory Medicinebusiness.industrySignificant differenceSeasonal coursePeak Expiratory Flow RateForced Expiratory Flow RatesMiddle AgedPrognosisCritical Care and Intensive Care Medicinemedicine.diseaseAsthmaCircadian RhythmPeak expiratory flow rate measurementForced Expiratory VolumeAnesthesiamedicineHumansFemaleRisk factorCardiology and Cardiovascular MedicinebusinessAsthmaMorningChest
researchProduct

Comparison of Peak Cough Flows Measured by Pneumotachograph and a Portable Peak Flow Meter

2004

To compare peak cough flows (PCF) obtained with a pneumotachograph (PCFp) with those measured using a portable peak flow meter (PCFm) in a population of healthy subjects and patients with neuromuscular disease.A total of 30 healthy subjects and 32 medically stable patients with neuromuscular diseases were studied. Using an oronasal mask connected, in a randomized order, to a pneumotachograph and to a portable peak flow meter, PCFp and PCFm were measured as every subject performed maximal cough efforts from total lung capacity.PCFp measurements were 377.70 +/-179.28 liters/min and PCFm measurements were 377.50 +/- 172.98 liters/min (not significant). The two measurements were correlated (r =…

AdultMalemedicine.medical_specialtyAdolescentPopulationPeak Expiratory Flow RatePhysical Therapy Sports Therapy and RehabilitationmedicineHumansLung volumeseducationAgededucation.field_of_studybusiness.industryRehabilitationHealthy subjectsNeuromuscular DiseasesMiddle AgedSurgeryClinical PracticePortable peak flow meterCoughFemaleFlowmetersNuclear medicinebusinessAmerican Journal of Physical Medicine &amp; Rehabilitation
researchProduct

Comparison of Lateral Abdominal Musculature Activation during Expiration with an Expiratory Flow Control Device Versus the Abdominal Drawing-in Maneu…

2020

Background and Objectives: The purpose of the present study was to quantify and compare lateral abdominal musculature thickness, including the transverse abdominis (TrA), internal oblique (IO), and external oblique (EO) muscles, via rehabilitative ultrasound imaging (RUSI) during the use of the expiratory flow control device (EFCD) versus the classic abdominal drawing-in maneuver (ADIM). Materials and Methods: A cross-sectional observational pilot study. Twenty-one women were recruited and assessed the thickness of each muscle (TrA, IO, and EO) by ultrasound imaging at rest, during the ADIM, and during expiration with the EFCD. Waist circumference was also measured under the same circumstan…

Adultmedicine.medical_specialtyMedicine (General)WaistMujerMedicinaDonesPeak Expiratory Flow RatePilot ProjectsFisiología humanaArticleabdominal musclesR5-920Abdominal musclesInternal medicineAbdominal drawing-in maneuverAbdomenmedicineHumansExpirationSistema musculoesqueléticoCiencias médicasUltrasonographymuscle activitybusiness.industryultrasonography; abdominal muscles; abdominal drawing-in maneuver; muscle activityGeneral MedicineultrasonographyMujeresAbdominal musculatureHealthy VolunteersCross-Sectional StudiesDuring expirationAbdominal musclesUltrasound imagingCardiologyabdominal drawing-in maneuverFemaleObservational studyUltrasonographybusinessMuscle activity
researchProduct

Non-specific bronchial hyper-responsiveness in children with allergic rhinitis: relationship with the atopic status

2003

An increased prevalence of bronchial hyper-responsiveness (BHR) has been demonstrated in children from a general population, and in non-asthmatic adults with allergic rhinitis. Thus, also children with allergic rhinitis are expected to be at higher risk of BHR. We evaluated the prevalence of BHR in a sample of non-asthmatic children with allergic rhinitis by means of the methacholine (Mch) bronchial challenge, and by monitorizing the airway patency using the daily peak expiratory flow variability (PEFv). Fifty-one children (ranged 6-15 years of age) with allergic rhinitis, ascertained by skin prick test to inhalant allergens, underwent a 14-day peak expiratory flow monitoring, and a Mch bro…

Cross-Sectional StudieHypersensitivity ImmediateMaleRhinitis Allergic PerennialAdolescentRespiratory Function Tests; Peak Expiratory Flow Rate; Airway Resistance; Vital Capacity; Bronchial Provocation Tests; Humans; Predictive Value of Tests; Child; Forced Expiratory Volume; Child Welfare; Cross-Sectional Studies; Rhinitis Allergic Perennial; Immunoglobulin E; Hypersensitivity Immediate; Bronchial Hyperreactivity; Statistics as Topic; Adolescent; Male; Biological Markers; Female; PrevalenceAirway ResistanceVital CapacityStatistics as TopicChild WelfarePeak Expiratory Flow RatePredictive Value of TestImmunoglobulin EBronchial Provocation TestForced Expiratory VolumeBiological MarkerPrevalenceFemaleBronchial HyperreactivityChildRespiratory Function TestHuman
researchProduct

Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controll…

2006

To evaluate the efficacy and tolerability of a novel hydrofluoroalkane (HFA) pressurised metered dose inhaler (pMDI) formulation of budesonide (Pulmicort) versus the conventional chlorofluorocarbon (CFC) pMDI formulation in paediatric patients with asthma.This was a Phase III, multicentre, 12-week, double-blind, randomised, parallel-group study involving children (6-12 years of age) with mild to moderate asthma. Patients received either budesonide HFA pMDI or budesonide CFC pMDI 200 mug twice daily, with or without a spacer (NebuChamber/Nebunette). Primary efficacy endpoint: mean percentage change in forced expiratory volume in 1 second (FEV(1)) from baseline to week 12. Secondary efficacy …

MaleBudesonideVital capacityHydrocarbons FluorinatedPeak Expiratory Flow Ratelaw.inventionchemistry.chemical_compoundDouble-Blind MethodRandomized controlled triallawmedicineHumansMetered Dose InhalersBudesonideChildAsthmaChlorofluorocarbonbusiness.industryInhalerGeneral Medicinemedicine.diseaseMetered-dose inhalerAsthmaBronchodilator AgentsTreatment OutcomeAerosol PropellantschemistryTolerabilityAnesthesiaFemaleChlorofluorocarbonsbusinessmedicine.drugCurrent Medical Research and Opinion
researchProduct

Computational fluid dynamics in the assessment of patients' postoperative status after glottis-widening surgery

2017

Background. Computational fluid dynamics (CFD), a rapidly developing instrument with a number of practical applications, allows calculation and visualization of the changing parameters of airflow in the upper respiratory tract. Objectives. The aim of this study was to demonstrate the advantages of CFD as an instrument for noninvasive tests of the larynx in patients who had undergone surgical treatment due to bilateral vocal fold paralysis. Material and Methods. Surface measurements of the glottic space were made during maximum adduction of the vocal folds. Additionally, the following spirometric parameters were determined: forced vital capacity (FVC), forced expiratory volume in the first s…

MalePatient-Specific ModelingLarynxVital capacityVital CapacityVideo RecordingMedicine (miscellaneous)Peak Expiratory Flow RateVocal Cords02 engineering and technologyForced Expiratory VolumePharmacology (medical)LungGenetics (clinical)Aged 80 and overPressure dropair flowMiddle Agedrespiratory system021001 nanoscience & nanotechnologyBiomechanical PhenomenaTreatment Outcomemedicine.anatomical_structureVocal foldsBreathingFemaleRadiologyCFD0210 nano-technologyVocal Cord ParalysisGlottismedicine.medical_specialtyGlottis0206 medical engineeringAirflowGeneral Biochemistry Genetics and Molecular BiologyFEV1/FVC ratioPhonationImage Interpretation Computer-AssistedInternal MedicinemedicineHumansAgedbilateral vocal fold paralysisLaryngoscopybusiness.industry020601 biomedical engineeringSpirometryCase-Control StudiesReviews and References (medical)HydrodynamicsbusinessSoftwareAdvances in Clinical and Experimental Medicine
researchProduct

Oral Sustained-Release Aminophylline and Bronchodilator Response to Inhaled Fenoterol in Patients with Chronic Airflow Obstruction

1985

The bronchodilator response to inhaled fenoterol (400 micrograms) was examined in the morning and in the afternoon before and during oral sustained-release aminophylline treatment in eight patients with chronic reversible airway obstruction. Bronchodilatation was evaluated by measuring serial peak expiratory flow rates (PEFR) for eight hours after inhaled fenoterol and calculating the area under the time-response curves and the percentage increment from the baseline values. The patients showed an enhancement of the bronchodilatation achieved with fenoterol in the morning during aminophylline treatment. In the afternoon, instead, the effect of the fenoterol was not improved by oral aminophyl…

MalePulmonary and Respiratory Medicinemedicine.drug_classPeak Expiratory Flow RateCritical Care and Intensive Care MedicineBronchodilatormedicineHumansLung Diseases ObstructiveFenoterolFenoterolMorningAerosolsInhalationbusiness.industryRespiratory diseaseMiddle Agedrespiratory systemAirway obstructionmedicine.diseaseAminophyllineBronchodilator AgentsBronchodilatationDelayed-Action PreparationsAnesthesiaDrug Therapy CombinationFemaleAminophyllineCardiology and Cardiovascular Medicinebusinessmedicine.drugChest
researchProduct

Lung function after acute and repeated exposures to extremely cold air (-110 degrees C) during whole-body cryotherapy.

2006

Whole-body cryotherapy (WBC) is one mode of cold therapy, during which rheumatic patients are exposed to very cold air (-110 degrees C) in minimal clothing. It is also proposed to have a bronchodilatory effect. The aim was to examine the effects of WBC on lung function in healthy humans after acute and repeated exposures. Twenty-five healthy, non-smoking subjects participated in the study. They were exposed to WBC for 2 min three times per week for 12 weeks. The peak expiratory flow rate (PEF) and forced expiratory volume in 1 s (FEV1) were measured before and after (at 2 and 30 min) the first WBC, and then similarly at 4, 8 and 12 weeks. At all time points, after 30 min of the WBC the PEF …

MaleTime FactorsPhysiologymedicine.medical_treatmentBronchoconstrictionCryotherapyPeak Expiratory Flow RateCold Therapyhemic and lymphatic diseasesPhysiology (medical)Statistical significanceForced Expiratory VolumemedicineHumansLung functionbusiness.industryWhole body cryotherapyCold airGeneral MedicineMiddle AgedRespiratory Function TestsBronchodilatationCryotherapyAnesthesiaRespiratory Physiological PhenomenaBronchoconstrictionFemalemedicine.symptombusinesscirculatory and respiratory physiologyClinical physiology and functional imaging
researchProduct